Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

BACKGROUND: Preoperative capecitabine-based chemoradiation is a standard treatment for locally advanced rectal cancer (LARC). Here, we explored the safety and efficacy of the addition of bevacizumab to capecitabine and concurrent radiotherapy for LARC. METHODS: Patients with MRI-confirmed stage II/I...

Descripción completa

Detalles Bibliográficos
Autores principales: Velenik, Vaneja, Ocvirk, Janja, Music, Maja, Bracko, Matej, Anderluh, Franc, Oblak, Irena, Edhemovic, Ibrahim, Brecelj, Erik, Kropivnik, Mateja, Omejc, Mirko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179720/
https://www.ncbi.nlm.nih.gov/pubmed/21880132
http://dx.doi.org/10.1186/1748-717X-6-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179720/
https://www.ncbi.nlm.nih.gov/pubmed/21880132
http://dx.doi.org/10.1186/1748-717X-6-105

Ejemplares similares